Authors:
Sperber, AD
Carmel, S
Atzmon, Y
Weisberg, I
Shalit, Y
Neumann, L
Fich, A
Friger, M
Buskila, D
Citation: Ad. Sperber et al., Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia, AM J GASTRO, 95(4), 2000, pp. 995-998
Authors:
Sibani, S
Leclere, D
Weisberg, I
Rozen, R
Citation: S. Sibani et al., The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with Mboll restriction isotyping of the reported A1298C mutation - Reply, MOL GEN MET, 68(4), 1999, pp. 512-512
Authors:
Sperber, AD
Weisberg, I
Skibin, A
Neumann, L
Fich, A
Buskila, D
Citation: Ad. Sperber et al., Serum interleukin-1, interleukin-2, interleukin-6, and prolactin levels are not associated with the severity of disease in patients with the irritable bowel syndrome, with or without concomitant fibromyalgia, J MUSCULO P, 7(4), 1999, pp. 15-27
Authors:
Sperber, AD
Carmel, S
Atzmon, Y
Weisberg, I
Shalit, Y
Neumann, L
Fich, A
Buskila, D
Citation: Ad. Sperber et al., The Sense of Coherence index and the irritable bowel syndrome - A cross-sectional comparison among irritable bowel syndrome patients with and withoutcoexisting fibromyalgia, irritable bowel syndrome non-patients, and controls, SC J GASTR, 34(3), 1999, pp. 259-263
Authors:
Sperber, AD
Atzmon, Y
Neumann, L
Weisberg, I
Shalit, Y
Abu-Shakrah, M
Fich, A
Buskila, D
Citation: Ad. Sperber et al., Fibromyalgia in the irritable bowel syndrome: Studies of prevalence and clinical implications, AM J GASTRO, 94(12), 1999, pp. 3541-3546